EE281 Trends in Approvals and Price at Market Entry of New Drugs for Breast Cancer in the US (1980-2022)

Abstract

Authors

A. Althomali E. Seoane-Vazquez

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×